CME Group Stock Rating Reaffirmed by Zacks (CME)
CME Group (NYSE:CME)‘s stock had its “neutral” rating reaffirmed by Zacks in a note issued to investors on Wednesday, AnalystRatingsNetwork.com reports. They currently have a $77.00 price objective on the stock. Zacks‘ price target suggests a potential upside of 4.61% from the stock’s previous close.
Several other analysts have also recently commented on the stock. Analysts at BMO Capital Markets cut their EPS estimates on shares of CME Group in a research note on Wednesday. They now have an “outperform” rating and a $85.00 price target on the stock. Separately, analysts at Citigroup Inc. downgraded shares of CME Group from a “buy” rating to a “neutral” rating in a research note to investors on Wednesday, January 8th. They now have a $82.00 price target on the stock. One analyst has rated the stock with a sell rating, twelve have given a hold rating and eight have given a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $71.34.
CME Group (NYSE:CME) traded down 0.08% during mid-day trading on Wednesday, hitting $73.55. The stock had a trading volume of 1,183,958 shares. CME Group has a 52 week low of $56.39 and a 52 week high of $84.71. The stock has a 50-day moving average of $77.26 and a 200-day moving average of $75.85. The company has a market cap of $24.665 billion and a price-to-earnings ratio of 25.82.
CME Group (NYSE:CME) last issued its quarterly earnings data on Tuesday, February 4th. The company reported $0.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.68 by $0.04. The company had revenue of $687.00 million for the quarter, compared to the consensus estimate of $691.29 million. During the same quarter in the previous year, the company posted $0.63 earnings per share. The company’s revenue for the quarter was up 3.9% on a year-over-year basis. Analysts expect that CME Group will post $3.60 EPS for the current fiscal year.
CME Group Inc (NYSE:CME) offers a range of global products across all asset classes based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, metals, weather and real estate.
To view Zacks’ full report, visit www.zacks.com
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.